Title: Martínez González S, et al. Identification of ETP-46321, a potent and orally bioavailable PI3K α, δ inhibitor. Bioorg Med Chem Lett. 2012 May 15;22(10):3460-6.
1355612-71-3 | Aldose reductase-IN-1 | AA009CDX | MFCD29472264
1313725-88-0 | Savolitinib | AA009CHF | MFCD28359096
131052-62-5 | 2(1H)-Pyridinone,6-(aminomethyl)-(9CI) | AA009CNI | MFCD12400743
142596-50-7 | 3-Methoxy-2-nitrobenzonitrile | AA009D3H | MFCD18382535
1364140-50-0 | 2-(3-TRIMETHOXYSILYLPROPYLTHIO)THIOPHENE | AA009DE0 | MFCD09953897
134151-66-9 | Benzoic acid, 4-[(1,2,2-trifluoroethenyl)oxy]- | AA009DRE | MFCD06411647
1232137-17-5 | 1-(5-tert-butyl-1H-pyrazol-3-yl)-N-methylmethanamine | AA009DV3 | MFCD13188550
1246820-50-7 | Carbutamide-d9 | AA009E1B
1246833-26-0 | Curcumin-d6 | AA009E7J | MFCD22570265
127140-69-6 | Clarithromycin Impurity H (10 mg) (N-formyl clarithromycin) | AA009EFU | MFCD28976073